W Ries

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

Jan Menne, Martin Nitschke, Robert Stingele et al. · BMJ · 2012 · 306 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +9

Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial

Gerd R. Hetzel, Martina Schmitz, H. Wissing et al. · Nephrology Dialysis Transplantation · 2010 · 252 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

Jan T. Kielstein, Gernot Beutel, Susanne Fleig et al. · Nephrology Dialysis Transplantation · 2012 · 236 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14

Characteristics of hypotension-prone haemodialysis patients: is there a critical relative blood volume?

Cláudia Barth, Walther H. Boer, Daniela Garzoni et al. · Nephrology Dialysis Transplantation · 2003 · 122 citations

Medicine, Nephrology, Dialysis +16

C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study

W Ries, Jan Torzewski, Franz Heigl et al. · Frontiers in Cardiovascular Medicine · 2021 · 68 citations · Full text

Veterinary Medicine, Cardiology, Pharmacotherapy +17